Jamie Lynn Case, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 941 Cherokee Dr, Suite 2a, Marshall, MO 65340 Phone: 660-831-1895 Fax: 660-831-1898 |
Ronald Renard, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 941 Cherokee Dr, Suite 2a, Marshall, MO 65340 Phone: 660-831-1895 Fax: 660-831-1898 |
Madison Maupin, DPT Physical Therapist - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 941 South Cherokee Street Suite 2a, Marshall, MO 65340 Phone: 660-831-1895 |
Rex E Harmon, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1251 Cherokee Dr, Suite 1, Marshall, MO 65340 Phone: 660-831-1895 Fax: 660-831-1898 |
Peak Performance Physical Therapy & Sports Medicine Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1251 Cherokee Dr, Suite 1, Marshall, MO 65340 Phone: 660-831-1895 Fax: 660-831-1898 |
Mrs. Michelle Harlin, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 941 Cherokee Dr, Suite 2a, Marshall, MO 65340 Phone: 660-831-1895 Fax: 660-831-1898 |
Serc - Marshall, Mo Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 E Morrow St, Ste 1, Marshall, MO 65340 Phone: 660-831-5108 Fax: 660-831-5126 |
News Archive
What keeps consumers hooked on high sugar soft drink? Advertising, of course. But why are some consumers more adept at ignoring these cues than others?
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of the ICOLabs Medical Review Application an innovative web based laboratory application that enables more efficient use of medical monitoring time.
Putting tobacco out of sight in shops not only changes young people's attitude to smoking but doesn't result in retailers losing money - according to new research published in Tobacco Control today (Friday).
Researchers at The University of Texas MD Anderson Cancer Center have discovered that a combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair achieved significant tumor regression in mouse models of small cell lung cancer, suggesting a promising new approach for treating patients with this aggressive cancer.
› Verified 2 days ago